“…In the United States, following vaccine implementation in 2006, rotavirus hospitalizations have declined 60-83% in children <5 years of age and all-cause diarrhea hospitalizations decreased by 29-50% compared with pre-vaccine years [24][25][26][27][28][29]. In addition to providing direct protection to vaccinated infants, indirect protection, likely from reduced rotavirus transmission in the community, has also been observed among children too old to have received the vaccine, as well as among adults in the United States [30][31][32]. One study estimated that over two seasons from 2008-2009, an estimated total of 60,000-80,000 diarrheal hospitalizations were prevented in young children resulting in a medical cost savings of $240-$280 million, and these saving have continued through subsequent rotavirus seasons [26,33].…”